# The U.S. Supreme Court has sided with drugmaker Hikma Pharmaceuticals, ruling that its generic version of Amarin Pharma's cardiovascular medication, Vascepa, does not infringe on any patents held by Amarin.

*biotech · news · 2026-06-06 · Devdiscourse*

## Key points

- The Supreme Court ruled 9-0 that Hikma's generic Vascepa does not infringe Amarin's patents.
- Justice Ketanji Brown Jackson authored the unanimous decision favoring generic drugmakers.
- The decision overturns a lower court ruling that had previously sided with Amarin.
- This ruling is likely to reduce generic drugmakers' vulnerability to 'skinny label' patent lawsuits.
- The decision may accelerate the availability of lower-cost generic drugs in the U.S.

In a landmark decision, the U.S. Supreme Court has sided with drugmaker Hikma Pharmaceuticals, ruling that its generic version of Amarin Pharma's cardiovascular medication, Vascepa, does not infringe on any patents held by Amarin. This decisive 9-0 ruling was authored by liberal Justice Ketanji Brown Jackson. The court's ruling is seen as a significant victory for generic drugmakers, as it might reduce their vulnerability to patent lawsuits, which often involve so-called 'skinny labels'. Such cases have historically been a barrier to producing lower-cost generic drugs. This decision overturns a lower court ruling that had favored Amarin. By potentially lowering the threshold for similar lawsuits in the future, the Court's ruling could encourage the production and sale of cost-effective generic drugs, which may, in turn, help to lower the high drug prices faced by consumers across the United States. (With inputs from agencies.)

**Companies:** Hikma Pharmaceuticals
**Countries:** United States

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/health/3931133-us-supreme-court-boosts-generic-drugmakers-in-skinny-label-patent-case)

---

Canonical: https://newsio.io/n/d44903da-b4c0-438e-bb2e-13625f1af6ff/the-u-s-supreme-court-has-sided-with-drugmaker-hikma-pharmaceuticals-ruling-that
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works